Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Sandu Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 16.10 0.65  | 4.21% -42.60% 18.27 11.40
BSE Price: Oct 15, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 15, 2019 16.10 0.65 4.21% 16.15 15.45 4,840 14.95 - 16.15
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 1,725 P/B: 0.58 NSE Code:
52-Week Range: R 12.00 - 30.45 Dividend Yield: 0.00% BSE Code: 524703
TTM EPS: R 0.88 Book Value: R 27.63 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Sandu Pharmaceuticals -32.92 1.58 -12.97 -42.60 -18.17 1.42 2.56
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 14.46 7.37 10.18
Net Profit 226.41 10.73 -6.35
EPS 226.41 10.72 -6.35
Book Value 4.58 0.74 0.93
Average
Operating Margin 5.28 6.02 6.25
Net Margin 1.14 0.47 0.77
Return on Networth 3.09 1.19 1.72
Return on Investment 7.06 6.67 6.75
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 3.57 11.13 0.97
Operating Profit 4.03 -29.34 -41.34
Net Profit 1,723.53 -4.62 3.33
EPS 1,724.17 -4.62 3.33
TTM
Revenue 2.50 -2.56 6.30
Operating Profit -8.44 -29.65 -5.68
Net Profit -2.35 -53.81 27.35
EPS -2.35 -53.82 27.34
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Sandu Pharmaceuticals 11.40 50.66 0.62 1.22 3.09 0.58 18.27
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 27, 2012 Bhaskar G Sandu  Buy Inter-Se Transfer 675,000 14.90 100.58
Jun 27, 2012 Shashank B Sandu  Buy Inter-Se Transfer 650,000 14.90 96.85
Jun 27, 2012 Umesh B Sandu  Buy Inter-Se Transfer 650,000 14.90 96.85
Aug 11, 2011 Jayashree B Sandu  Buy Inter-Se Transfer 1,914,000 13.84 264.90
Aug 11, 2011 Sandhya K Deshpande  Sell Off Market 1,914,000 13.84 264.90
News & Announcements
Contact Information

Company: Sandu Pharmaceuticals Ltd.

Address: Plot No 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Bardez, Goa - 403511 | Phone: +91-832-2407473/2407474/2841044 | Fax: +91-832-2407008

Email: [email protected]

Website: www.sandu.in

Registrar & Transfer Agent: Sharex Dynamic (India) Pvt Ltd

Address: Unit -1, Luthra Ind. Premises , Safed Pool,Andheri-Kurla Road,Andheri (E),Mumbai, Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E) | Phone: 022-28515606/5644 | Fax: 022-28512885

Email: [email protected]

Essential checks
Altman Z-Score
2.50
Piotroski F-Score
7
Modified C-Score
4
5-Years Price to Earnings
18.27
5-Years Price to Book
0.58
Earnings Yield
EBIT / Enterprise value
9.42%
PEG
Price / Earnings to growth ratio
3.82
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59